TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/9/24 18:04 | 7/5/24 | CRNX | Crinetics Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hassard James | CA | O | Chief Co | M.d | 296 | 19.73 | 0 | 15 | 105 | 29 | D | ||||||||||||||
7/9/24 18:04 | 7/5/24 | CRNX | Crinetics Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hassard James | CA | O | Chief Co | S.d | -661 | 44.08 | 0 | -15 | -34 | 29 | D | ||||||||||||||
6/24/24 17:08 | 6/21/24 | CRNX | Crinetics Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hassard James | CA | O | Chief Co | M.d | 296 | 19.73 | 0 | 15 | 105 | 29 | D | ||||||||||||||
6/24/24 17:08 | 6/21/24 | CRNX | Crinetics Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hassard James | CA | O | Chief Co | S.d | -670 | 44.66 | 0 | -15 | -34 | 29 | D | ||||||||||||||
6/24/21 18:44 | 6/22/21 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hassard James | CA | O | Chief Co | S | -323 | 89.22 | 0 | -4 | -3 | 106 | D | ||||||||||||||
1/8/21 18:05 | 1/7/21 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hassard James | CA | O | Chief Co | S | -1,172 | 75.00 | 0 | -16 | -13 | 109 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |